<![CDATA[Introduction: Metabolic risks are major contributors to the burden of non-communicable diseases, but recent patterns of metabolic risk-attributable mortality in Indonesia have not been well characterized. Purpose: This study described national trends in metabolic risk-attributable mortality from 2019 to 2023, selected component risks, and the age distribution of attributable deaths. Methods: A descriptive trend analysis was conducted using aggregate estimates from the Global Burden of Disease Study 2023. Absolute deaths and age-standardized death rates (ASDRs) were examined annually, five selected metabolic risks were ranked in 2019 and 2023, and attributable deaths were assessed across age groups. No statistical trend modeling or causal inference was performed. Results: Metabolic risk-attributable deaths increased from 637,490 (95% uncertainty interval [UI]: 565,765–705,015) in 2019 to 713,661 (612,990–818,742) in 2023 (+11.95%), whereas the ASDR declined by 2.11%, from 296.53 to 290.27 deaths per 100,000 population. High systolic blood pressure remained the leading selected risk, while high body mass index showed the largest relative increase (+17.29%). In 2023, 14.99%, 50.07%, and 34.82% of attributable deaths occurred among those aged 15–49, 50–69, and ≥70 years, respectively. Conclusion: Absolute metabolic risk-attributable mortality increased despite a modest decline in the ASDR, with the burden concentrated among adults aged ≥50 years. These descriptive patterns do not establish causal effects of the COVID-19 pandemic or other contextual factors.]]>
